Macfarlane K. Angela has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 47640 shares of RenovoRx, Inc. ($RNXT) on October 01, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2025 | RenovoRx, Inc. | $RNXT | Macfarlane K. Angela | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| Oct. 1, 2024 | RenovoRx, Inc. | $RNXT | Macfarlane K. Angela | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Macfarlane K. Angela | Director | P | Common Stock | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Macfarlane K. Angela | Director | P | Warrant Shares | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |